REYON Pharmaceutical Co., Ltd. (KRX:102460)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,830.00
0.00 (0.00%)
At close: Jun 24, 2026
Market Cap180.29B -9.4%
Revenue (ttm)145.22B -1.9%
Net Income-40.59B
EPS-2,202.86
Shares Out 18.34M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume101,500
Open9,800.00
Previous Close9,830.00
Day's Range9,490.00 - 9,860.00
52-Week Range9,100.00 - 14,430.00
Beta0.41
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About REYON Pharmaceutical

REYON Pharmaceutical Co., Ltd. manufactures and sells medicines. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; antibiotics; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; ... [Read more]

Sector Healthcare
Founded 1955
Employees 440
Stock Exchange Korea Stock Exchange
Ticker Symbol 102460
Full Company Profile

Financial Performance

Financial Statements